Castle Historical Income Statement
| CSTL Stock | USD 30.44 0.13 0.43% |
Historical analysis of Castle Biosciences income statement accounts such as Net Interest Income of 10.3 M, Interest Income of 10.3 M or Discontinued Operations of 0.0 can show how well Castle Biosciences performed in making a profits. Evaluating Castle Biosciences income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Castle Biosciences's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Castle Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Castle Biosciences is a good buy for the upcoming year.
Castle |
About Castle Income Statement Analysis
Castle Biosciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Castle Biosciences shareholders. The income statement also shows Castle investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Castle Biosciences Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Castle Biosciences generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Castle Biosciences minus its cost of goods sold. It is profit before Castle Biosciences operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Castle Biosciences. It is also known as Castle Biosciences overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from Castle Biosciences' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Castle Biosciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Castle Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Castle Stock please use our How to buy in Castle Stock guide.At this time, Castle Biosciences' Gross Profit is quite stable compared to the past year. Other Operating Expenses is expected to rise to about 302.2 M this year, although the value of Selling General Administrative will most likely fall to about 50.2 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 1K | 17K | 11K | 10.5K | Depreciation And Amortization | 3.4M | 10.5M | 12.3M | 12.9M |
Castle Biosciences income statement Correlations
Click cells to compare fundamentals
Castle Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Castle Biosciences income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Tax Provision | 72K | 84K | (8.7M) | (1.8M) | 119K | 125.0K | |
| Net Interest Income | (4.3M) | (2.3M) | 67K | 4.0M | 9.8M | 10.3M | |
| Interest Income | 312K | 373K | 68K | 4.0M | 9.8M | 10.3M | |
| Depreciation And Amortization | 358K | 472K | 3.4M | 10.5M | 12.3M | 12.9M | |
| Interest Expense | 4.6M | 2.6M | 1K | 17K | 11K | 10.5K | |
| Selling General Administrative | 29.8M | 48.1M | 86.7M | 56.4M | 66.5M | 50.2M | |
| Total Revenue | 51.9M | 62.6M | 94.1M | 137.0M | 219.8M | 230.8M | |
| Gross Profit | 44.6M | 53.0M | 78.3M | 105.0M | 174.8M | 183.5M | |
| Other Operating Expenses | 44.5M | 69.2M | 134.2M | 228.2M | 287.8M | 302.2M | |
| Operating Income | 4.7M | (6.5M) | (40.1M) | (91.1M) | (68.0M) | (64.6M) | |
| Net Income From Continuing Ops | 5.3M | (10.3M) | (31.3M) | (67.1M) | (75.5M) | (71.7M) | |
| Ebit | 4.7M | (7.6M) | (40.0M) | (68.9M) | (57.4M) | (54.5M) | |
| Research Development | 7.4M | 13.3M | 29.6M | 44.9M | 53.6M | 56.3M | |
| Ebitda | 5.1M | (7.1M) | (36.6M) | (58.3M) | (45.0M) | (42.8M) | |
| Cost Of Revenue | 7.3M | 9.7M | 15.8M | 32.0M | 45.0M | 47.2M | |
| Total Operating Expenses | 37.2M | 59.5M | 118.3M | 196.2M | 242.8M | 254.9M | |
| Reconciled Depreciation | 358K | 472K | 3.4M | 10.5M | 11.9M | 12.5M | |
| Income Before Tax | 5.3M | (10.2M) | (40.0M) | (68.9M) | (57.4M) | (54.5M) | |
| Total Other Income Expense Net | 642K | (3.7M) | 67K | 4.0M | 10.6M | 11.1M | |
| Net Income Applicable To Common Shares | 3.0M | (10.3M) | (31.3M) | (67.1M) | (60.4M) | (57.4M) | |
| Net Income | 5.3M | (10.3M) | (31.3M) | (67.1M) | (57.5M) | (54.6M) | |
| Income Tax Expense | 72K | 84K | (8.7M) | (1.8M) | 101K | 106.1K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in Castle Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Castle Stock please use our How to buy in Castle Stock guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Castle Biosciences. If investors know Castle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Castle Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.93) | Earnings Share 0.21 | Revenue Per Share 11.34 | Quarterly Revenue Growth 0.395 | Return On Assets (0) |
The market value of Castle Biosciences is measured differently than its book value, which is the value of Castle that is recorded on the company's balance sheet. Investors also form their own opinion of Castle Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Castle Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Castle Biosciences' market value can be influenced by many factors that don't directly affect Castle Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Castle Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Castle Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Castle Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.